戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 % CI, 1.84-4.16; both p < 0.001) compared to crystalloid.
2 6) were initially resuscitated with 10 mL/kg crystalloid.
3 ge vacuoles, they form a membrane-containing crystalloid.
4 , pigs were resuscitated with shed blood and crystalloid.
5 ong trauma patients is unknown compared with crystalloid.
6 s not more effective than treating with only crystalloids.
7 received synthetic colloids compared to only crystalloids.
8 eved equally fast with synthetic colloids or crystalloids.
9 branes adjacent to granular material and DNA crystalloids.
10  health record to compare saline to balanced crystalloids.
11 tion of intravenous fluids that was balanced crystalloids.
12 nal hemodynamics when compared with balanced crystalloids.
13      Intraoperatively, LIB patients received crystalloid 12 mL/kg/h and RES patients 6 mL/kg/h.
14  age, gender, comorbidities, blood products, crystalloid/12 hrs, presence of any head injury, injury
15       Patients received a median of 6.1 L of crystalloid, 13 units of RBCs, 10 units of FFP, and 1 un
16 nosis (1C); initial fluid resuscitation with crystalloid (1B) and consideration of the addition of al
17           Here we show that formation of the crystalloid-a unique and short-lived organelle of the Pl
18 se virions do not acquire nucleoids, and DNA crystalloids accumulate in the cytoplasm.
19 n study groups in the proportion of isotonic crystalloid administered that was saline.
20 ndomized controlled trial comparing balanced crystalloid against 5% HAS as sole early resuscitation f
21 ible trials comparing hydroxyethyl starch to crystalloids, albumin, or gelatin.
22 n addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival
23 er infusion of blood products is superior to crystalloids alone.
24  of 1162 patients (99.1%) receiving buffered crystalloid and 1110 of 1116 patients (99.5%) receiving
25  and retrograde cardioplegia are superior to crystalloid and antegrade cardioplegia alone for postope
26 logical effects of ONOO(-) may exist between crystalloid and blood cardioplegia (BCP) environments.
27 ndergoing DCL, implementation of DCR reduces crystalloid and blood product administration.
28                               After 30 mins, crystalloid and blood with either 0.1 unit x kg(-1) x hr
29 id resuscitation with commercially available crystalloid and colloid solutions only provides transien
30 erformed to a target hemoglobin of 8.0 g/dL; crystalloid and colloid were used for volume replacement
31 ion at the sites was equally divided between crystalloid and crystalloid + PRBC.
32 ow-dose dopamine (n = 43) versus intravenous crystalloid and matching placebos (n = 55).
33 gulated with citrate-phosphate-dextrose) and crystalloid and observed for the next 6 or 24 hours.
34 ter LVR, full resuscitation was started with crystalloid and red cells.
35                  Improved resuscitation with crystalloid and shed blood minimized acute lung injury.
36 thy through permissive hypotension, limiting crystalloids and delivering higher ratios of plasma and
37 e family Brassicaceae, the PSVs lack visible crystalloids and have many small globoids dispersed thro
38 e examined the association between choice of crystalloids and in-hospital mortality during the resusc
39 on, and pigs were resuscitated with isotonic crystalloids and norepinephrine for 4.25 h.
40 lution may maintain hemodynamics better than crystalloids and reduce the decrease in platelet count a
41 -embedded proteins (BPEPs), associated with 'crystalloid' and globoid fractions.
42 ion to give is, whether it be a colloid or a crystalloid, and how and when to give it.
43 lline lattice of membranes and proteins, the crystalloid, and one or a few large phytate crystals, th
44 rising estimated blood loss, total volume of crystalloid, and other colloid/hypertonic solutions admi
45     Saline, glucose-containing high chloride crystalloids, and balanced crystalloids represented 43%,
46    Hyponatremia was apparent in the isotonic crystalloid- and colloid-treated animals, but not in tho
47 decades after they were first described, the crystalloids are back in the spotlight, with recent disc
48                                              Crystalloids are malaria parasite organelles exclusive t
49                                     Isotonic crystalloids are recommended for initial fluid therapy i
50 sified as crystalloids or colloids, and most crystalloids are sodium salts.
51                                              Crystalloids are transient organelles that form in devel
52 compared with 22 participants (14.8%) in the crystalloid arm (adjusted odds ratio, 1.50; 95% CIs, 0.8
53    There was lower mortality in the balanced crystalloid arm.
54        International guidelines recommend IV crystalloid as the primary fluid for sepsis resuscitatio
55 es, anesthetic management, fluid management (crystalloids as well as hemoglobin-based oxygen-carrying
56 hock, fluid resuscitation with MES (balanced crystalloid) as compared with 0.9% saline resulted in a
57 e sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did n
58 8 hr) comprised retransfusion of shed blood, crystalloids (balanced electrolyte solution), and norepi
59 use of damage control surgery and aggressive crystalloid-based resuscitation.
60  to 90 minutes postorder; and 4) 30 mL/kg IV crystalloid bolus initiated less than or equal to 30 min
61 ) identify predictors of reaching a 30 mL/kg crystalloid bolus within 3 hours of sepsis onset (30by3)
62 lloids (p<.05) and, to a lesser extent, with crystalloids, but not with albumin.
63  at baseline and received similar volumes of crystalloid by 30 days (median [interquartile range]: 1,
64                It is generally believed that crystalloid can be substituted, in whole or in part, for
65 ossover trial comparing saline with balanced crystalloids can produce well-balanced study groups and
66  arrested for 30 minutes (37 degrees C) with crystalloid cardioplegia (CCP).
67 in microbubbles within the myocardium during crystalloid cardioplegia (CP) infusion and ischemia-repe
68 earts were arrested for 60 minutes with cold crystalloid cardioplegia (iC-CCP; n=8) or with cold bloo
69 sted for 60 minutes with warm (37 degrees C) crystalloid cardioplegia (iW-CCP) (n=8) or with warm blo
70  followed by 60 minutes of intermittent cold crystalloid cardioplegia (Plegisol) and 2 hours of reper
71 he hypothesis that ONOO(-) is cardiotoxic in crystalloid cardioplegia but cardioprotective in BCP in
72 arts to 8 hours of hypothermic ischemia with crystalloid cardioplegia containing adenosine 0, 0.01, 0
73                                       GSH in crystalloid cardioplegia detoxifies ONOO(-) and forms ca
74  investigated whether intermittent blood and crystalloid cardioplegia differentially affect myocardia
75    Extent of myocardial protection with cold-crystalloid cardioplegia in pediatric open heart surgery
76                                   ONOO(-) in crystalloid cardioplegia solution induces injury to coro
77                           Patients receiving crystalloid cardioplegia versus those receiving blood ca
78 sis) undergoing open heart surgery with cold-crystalloid cardioplegia were included in the study.
79 y donor hearts preserved by single dose cold crystalloid cardioplegia with greater than 8 hours of co
80 500 micromol/L GSH, whereas 1 group received crystalloid cardioplegia without GSH (CCP, n=6).
81 wed by 60 minutes of CPB, with 45 minutes of crystalloid cardioplegia, then 90 minutes of post-CPB re
82 to enhance myocardial protection afforded by crystalloid cardioplegia, volatile anesthesia and hypoth
83 jury in pediatric patients protected by cold-crystalloid cardioplegia.
84 ompared with respect to the use of blood and crystalloid cardioplegia.
85 nction and systolic function when present in crystalloid cardioplegia.
86 dioplegic arrest and rewarming, incubated in crystalloid cardioplegic solution (24 mEq/L K+, 4 degree
87  the partial dilution of blood in 4:1 (blood:crystalloid) cardioplegic solutions may nullify these ad
88 balance, accounting for patient morphometry, crystalloid, colloid, blood products, urine, blood loss,
89                                         The 'crystalloid-colloid debate' continues, and has led to an
90 rhage should occur in successive steps using crystalloids, colloids, and red blood cells (RBCs) in th
91                                              Crystalloids, colloids, blood, inotropes, and vasopresso
92 tional coagulopathy after resuscitation with crystalloids/colloids clinically often appears as diffus
93  fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk
94  substantial mortality benefit from balanced crystalloids compared with normal saline.
95 al mortality reduction from used of balanced crystalloids compared with normal saline.
96 mental therapy for sepsis, but the effect of crystalloid composition on patient outcomes remains unkn
97 rious ice nucleating proteins, microbes, and crystalloid compounds.
98                                              Crystalloid CP perfusion and I-R resulted in extensive l
99 bubble transit was markedly prolonged during crystalloid CP perfusion.
100 effect was partially reversed in the case of crystalloid CP when it was followed by blood CP.
101 nts with hypovolemia, the use of colloids vs crystalloids did not result in a significant difference
102   Consistent with other proteins that induce crystalloid ER, viperin self-associates, and it does so
103 phipathic alpha-helix fused to dsRed induced crystalloid ER.
104               Participants received 1-3 L of crystalloid fluid for initial fluid resuscitation before
105                     Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered
106   All patients admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion.
107                              All measures of crystalloid fluid volume were reduced while patients wer
108 esuscitation with blood or a large volume of crystalloid fluid.
109 CPR is a rapid infusion of large-volume cold crystalloid fluid.
110 al ligation and puncture model incorporating crystalloid fluids and antibiotics, exhibiting improved
111 vity as the result of dilution followed with crystalloid fluids and artificial colloids (dextran and
112  participants had received on average 430 mL crystalloid fluids and tranexamic acid (90%).
113 ne of the first precision medicine trials of crystalloid fluids in sepsis.
114  remains clinical equipoise on which type of crystalloid fluids to use in sepsis.
115 nce between designs (hyperoncotic albumin vs crystalloid fluids) among these 18 comparisons.
116  regarding saline as the primary intravenous crystalloid for critically ill adults and highlights fun
117 Database, the use of a calcium-free balanced crystalloid for replacement of fluid losses on the day o
118               Therapy in the Colloids Versus Crystalloids for the Resuscitation of the Critically Ill
119 ked study fluid, either saline or a buffered crystalloid, for alternating 7-week treatment blocks.
120 s of developing ookinetes and is involved in crystalloid formation.
121             Forced diuresis with intravenous crystalloid, furosemide, and mannitol if hemodynamics pe
122 ndomized to forced diuresis with intravenous crystalloid, furosemide, mannitol (if pulmonary capillar
123                                   Cumulative crystalloid given (median, range, mL) days 0 to 3 was LI
124  made up a larger proportion of the isotonic crystalloid given in the saline group than in the balanc
125 thetized pig can be reversed or prevented by crystalloids given in a volume equivalent to Advanced Tr
126 ed eosinophils, which were probably immature crystalloid granules in eosinophil myelocytes.
127 ven in the saline group than in the balanced crystalloid group (91% vs. 21%; P < 0.001).
128 luid was needed over the first 4 days in the crystalloid group (fluid ratios 1.4:1 [crystalloids to h
129 , 87 of 1152 patients (7.6%) in the buffered crystalloid group and 95 of 1110 patients (8.6%) in the
130  albumin group and 288 of 900 (32.0%) in the crystalloid group had died (relative risk in the albumin
131  albumin group and 389 of 893 (43.6%) in the crystalloid group had died (relative risk, 0.94; 95% CI,
132               Fluid intake was higher in the crystalloid group only during the first 20 hours.
133                              In the buffered crystalloid group, 102 of 1067 patients (9.6%) developed
134 albumin group, as compared with those in the crystalloid group, had a higher mean arterial pressure (
135                              In the buffered crystalloid group, RRT was used in 38 of 1152 patients (
136 ay 5, fluid balance was more negative in the crystalloid group.
137 red with a net positive fluid balance in the crystalloid group.
138 ) in colloids group vs 390 deaths (27.0%) in crystalloids group (relative risk [RR], 0.96 [95% CI, 0.
139 ) in colloids group vs 493 deaths (34.2%) in crystalloids group (RR, 0.92 [95% CI, 0.86 to 0.99]; P =
140  (11.0%) in colloids group vs 181 (12.5%) in crystalloids group (RR, 0.93 [95% CI, 0.83 to 1.03]; P =
141 cal ventilation in the colloids group vs the crystalloids group by 7 days (mean: 2.1 vs 1.8 days, res
142 otal of 217 patients (26.3%) in the balanced crystalloids group experienced 30-day in-hospital morali
143                                     Balanced crystalloids have a sodium, potassium, and chloride cont
144 wed higher mortality with starches than with crystalloids (high confidence) and lower mortality with
145 ocol groups: euvolemic (3 mLkg/hour isotonic crystalloid), hypervolemic (15 mL/kg/hour isotonic cryst
146    Isotonic saline is the most commonly used crystalloid in the ICU, but recent evidence suggests tha
147 gelatin in 2006-2008, n = 2,324; and 3) only crystalloids in 2008-2010, n = 2,017.
148 ity of human albumin solutions compared with crystalloids in improving major outcomes, short-term adm
149 RTICIPANTS: The Precision Resuscitation With Crystalloids in Sepsis (PRECISE) trial is a parallel-gro
150 d, 4% gelatin in the second period, and only crystalloids in the third period.
151 orrhagic shock may receive several liters of crystalloid, in addition to colloid solutions, in an att
152 um with accumulation of large phagosomes and crystalloid inclusions.
153                                            A crystalloid infusion of 0.9% saline did not alter any of
154                                              Crystalloid infusion revealed best results in mortality
155 6 and resulted in a decrease in mean 24-hour crystalloid infusion volume (6.1-3.2 L) and increased fr
156                             The mean 24-hour crystalloid infusion volume and number of the total bloo
157 venous pressure was kept constant by colloid/crystalloid infusion.
158  three hundred thirty-six patients (48%) had crystalloid initiated in 30 minutes or lesser versus 2,3
159                                      Earlier crystalloid initiation was associated with decreased mor
160                                              Crystalloid initiation was faster for emergency departme
161                     The primary exposure was crystalloid initiation within 30 minutes or lesser, 31-1
162 and ICUs to nudge clinicians to use balanced crystalloids instead of normal saline.
163 ntensive care unit volume, and initial 24-hr crystalloid intensive care unit volume were all lower in
164 ume during the first 48 hrs post burn, total crystalloid intensive care unit volume, and initial 24-h
165 n saline (0.9% sodium chloride) and balanced crystalloids (lactated Ringer's solution or Plasma-Lyte
166 o Obviate Lung Injury]) and sepsis (CLOVERS [Crystalloid Liberal or Vasopressors Early Resuscitation
167  cohort study is a secondary analysis of the Crystalloid Liberal vs Early Vasopressors in Sepsis (CLO
168 nated PSVs from Brassica napus and defined a crystalloid-like fraction that contained integral membra
169 d-volume colloid (LV-Co), and limited-volume crystalloid (LV-Cr) resuscitation on the gut microbiota,
170                   DCR patients received less crystalloids (median: 14 L vs 5 L), red blood cells (13
171 ) and lower mortality with albumin than with crystalloids (moderate confidence) or starches (moderate
172 ovolemia to achieve a minimum of 30 mL/kg of crystalloids (more rapid administration and greater amou
173 yethyl starch n = 360, gelatin n = 352, only crystalloids n = 334).
174 yethyl starches, or 4% or 20% of albumin) or crystalloids (n = 1443; isotonic or hypertonic saline or
175 ts assigned to saline (n = 454) and balanced crystalloids (n = 520) were similar at baseline and rece
176          Animals were treated with different crystalloids (NaCl 0.9% (NaCl), Ringer's acetate (RA)) o
177 ed in macrogametocytes, gets targeted to the crystalloids of developing ookinetes and is involved in
178 d integral membrane protein markers found in crystalloids of other plants.
179                                              Crystalloid only had the worst survival.
180  at risk for hemorrhagic shock compared with crystalloid only resuscitation.
181 HR 0.68; 95% CI 0.49-0.95, P = 0.025) versus crystalloid only.
182 s led to 4 prehospital resuscitation groups: crystalloid only; PRBC; plasma; and PRBC+plasma.
183  reduction in 30-day mortality compared with crystalloid-only resuscitation.
184         IV fluid resuscitation with balanced crystalloid or 5% HAS for the first 6 hours following ra
185 chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid c
186 uence of volume resuscitation with different crystalloid or colloid solutions on liver and intestine
187                                   Low-volume crystalloid or hemoglobin glutamer-200 resuscitation pos
188 nts with sepsis, resuscitation with balanced crystalloids or albumin compared with other fluids seems
189 hock associated with hypovolemia, the use of crystalloids or albumin to deliver a bolus of 20 mL/kg o
190                     IVF can be classified as crystalloids or colloids, and most crystalloids are sodi
191      However, whether balanced or unbalanced crystalloids or natural or synthetic colloids confer a s
192 or albumin to deliver a bolus of 20 mL/kg of crystalloids (or albumin equivalent) over 5 to 10 mins (
193 lloid), hypervolemic (15 mL/kg/hour isotonic crystalloid), or hypertonic (3 mL/kg/hour isotonic cryst
194 dentify a parasite protein involved with the crystalloid organelle, and suggest a novel protein-traff
195  induced formation of karmellae, whorls, and crystalloid OSER structures.
196 indicated that AQP1 plays a critical role in crystalloid osmosis, with clinically relevant effects on
197 rovessels, leading to a rapid decline of the crystalloid osmotic gradient, thereby decreasing aquapor
198 sion of 1, 2, 3, or 4 mL/Kg (body weight) of crystalloid over 5 minutes.
199 some monocotyledonous plants, but additional crystalloid P-proteins, known as forisomes, have evolved
200  patients received more fluid (4.0 vs. 2.5 L crystalloid, p < .001), earlier antibiotics (90 vs. 120
201                     Isolated rat hearts were crystalloid perfused with the Langendorff method and sub
202         These results contrast with isolated crystalloid-perfused heart experiments and suggest that
203  In additional experiments, using blood- and crystalloid-perfused hearts, we describe the relationshi
204                                 The isolated crystalloid-perfused working rat heart preparation was u
205 e have developed a simplified system of cold crystalloid perfusion and compared it with standard cold
206                              Continuous cold crystalloid perfusion in a canine model of DCD: (1) faci
207 l starch and gelatin periods compared to the crystalloid period (odds ratio, 1.46 [1.08, 1.97]; p = 0
208  in the gelatin period, and 224 mL/kg in the crystalloid period.
209 mponents of forisomes, which are specialized crystalloid phloem proteins found solely in the Fabaceae
210 ts were randomized to receive either PGE1 or crystalloid placebo intravenously after allograft revasc
211 tes of intermittent 4 degrees C hyperkalemic crystalloid (Plegisol) or BCP with (+) or without (-) 5
212 lloid), or hypertonic (3 mL/kg/hour isotonic crystalloid plus 1.2 mL/kg/hour 7.5% NaCl).
213 hour, then resuscitation with shed blood and crystalloid, plus contamination).
214  was equally divided between crystalloid and crystalloid + PRBC.
215    Patients received a 5% albumin prime or a crystalloid prime.
216 4 patients had an albumin prime and 42 had a crystalloid prime.
217                      Whether use of balanced crystalloids rather than saline affects patient outcomes
218 g room have demonstrated that using balanced crystalloids rather than saline prevents the development
219 well-balanced study groups and separation in crystalloid receipt.
220 ing high chloride crystalloids, and balanced crystalloids represented 43%, 27%, and 16% of total volu
221 of the crystalloid, the correct targeting of crystalloid-resident protein LAP2, and malaria parasite
222 ly ill adults have examined whether balanced crystalloids result in less death or severe renal dysfun
223                                 Large volume crystalloid resuscitation can be deleterious.
224  of the 40-year-old standard of large volume crystalloid resuscitation for traumatic shock, greatly r
225 ults with severe falciparum malaria received crystalloid resuscitation guided by transpulmonary therm
226   Recognition of the limitations of standard crystalloid resuscitation has led to exploration for alt
227 e significant public health implications, as crystalloid resuscitation is nearly universal in sepsis.
228    The majority recovered well with standard crystalloid resuscitation or following a single colloid
229 is study were to 1) assess patterns of early crystalloid resuscitation provided to sepsis and septic
230  control and preload driven excessive use of crystalloid resuscitation were identified as modifiable
231 mine the association between time to initial crystalloid resuscitation with hospital mortality, mecha
232 blood was returned, i.e., immediately before crystalloid resuscitation, and were killed at 2 hrs afte
233  shock with tissue trauma (HS/T) followed by crystalloid resuscitation.
234 ve shown that resuscitation with colloid and crystalloid show no difference in outcomes in critically
235 e administration of only a minimal volume of crystalloid solution (2.8 mL/kg) and the absence of bloo
236  0.9% saline (30,994 patients) or a balanced crystalloid solution (926 patients) on the day of surger
237 on, fluid resuscitation was initiated with a crystalloid solution (Lactated Ringers).
238                   In addition, the volume of crystalloid solution administered during the first 24 hr
239 ther 20% albumin and crystalloid solution or crystalloid solution alone.
240                    Pharmacologic modulation, crystalloid solution at 4 degrees C, and induction of he
241 ed method for infusion of O2, dissolved in a crystalloid solution at extremely high concentrations, i
242 reserved by perfusion with a cold oxygenated crystalloid solution for 4 h, transferred to a blood per
243 depend on its environment and (2) ONOO(-) in crystalloid solution impairs postcardioplegia systolic a
244 ts (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone.
245  either an intravenous infusion of 500 mL of crystalloid solution or no fluid bolus.
246 LP induced septic rats, whereas the balanced crystalloid solution showed stabilization of macro- and
247  is a physiologic, balanced multielectrolyte crystalloid solution that approximates the electrolyte c
248 ersus Plasma-Lyte A, a calcium-free balanced crystalloid solution, hypothesizing that Plasma-Lyte A w
249  modify authentic platelets in a nonclinical crystalloid solution.
250                                     Balanced crystalloid solutions (e.g., lactated Ringer's, Plasma-L
251 o determine whether the volumes of blood and crystalloid solutions administered in the early posttrau
252 tion to albumin and crystalloid solutions or crystalloid solutions alone.
253 d debate continues about the role of various crystalloid solutions and albumin.
254 ume-dependent and linear fashion, the non-RL crystalloid solutions decreased the lactate concentratio
255 porting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shoc
256              c) Even small amounts of non-RL crystalloid solutions in catheters used for blood sampli
257 on of therapeutic components, beginning with crystalloid solutions infused to replace lost intravascu
258     Rationale: Administration of intravenous crystalloid solutions is a fundamental therapy for sepsi
259 ens are drawn from indwelling catheters, all crystalloid solutions must be cleared from the line.
260                 Randomization to albumin and crystalloid solutions or crystalloid solutions alone.
261                                     Balanced crystalloid solutions such as Lactated Ringer are associ
262 albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different mo
263 0.01, 0.05, 0.10, 0.50, or 1.0 mL of various crystalloid solutions, containing or not containing RL,
264  deleterious effects of nitric oxide (NO) in crystalloid solutions, possibly due to a lack of detoxif
265 st the hypothesis that even small amounts of crystalloid solutions, which are inadequately "cleared"
266  were adequately cleared (removal > 5 mL) of crystalloid solutions.
267                The CNTL involved intravenous crystalloid solutions.
268 ared to WT fruit as well as lower density of crystalloid structures on berry surfaces.
269 otein was targeted to peroxisomes and formed crystalloid structures or cores similar to those present
270        He was immediately resuscitated using crystalloids, supported with inotrope, and antibiotics.
271   Elamipretide-treated animals required less crystalloids than the controls (62.5 [50-90] and 25 [5-3
272 ht starch (low confidence) and with balanced crystalloids than with saline (low confidence) and low-
273 rotein is essential for the formation of the crystalloid, the correct targeting of crystalloid-reside
274 s article we review recent studies involving crystalloids, the 'new colloids', and on the amount and
275 o continue to require substantial amounts of crystalloid to maintain adequate mean arterial pressure
276  resuscitated with shed autologous blood and crystalloid to reach baseline cardiac output (0.9%), and
277 stalloids to hydroxyethyl starch] and 1.1:1 [crystalloids to gelatin]).
278 n the crystalloid group (fluid ratios 1.4:1 [crystalloids to hydroxyethyl starch] and 1.1:1 [crystall
279                          Among these are the crystalloids: transient structures whose presence is res
280     After 1 hr, shed blood plus supplemental crystalloid (twice the shed blood volume) plus either ac
281                              The intravenous crystalloid used in the unit alternated monthly between
282 s 4% blood cardioplegia) and late death (24% crystalloid versus 21% blood cardioplegia) statistics we
283                Despite this, early death (6% crystalloid versus 4% blood cardioplegia) and late death
284           Rationale: The effects of balanced crystalloid versus saline on clinical outcomes for ICU p
285 bjectives: To compare the effect of balanced crystalloids versus saline on 30-day in-hospital mortali
286      There has been a shift toward a reduced crystalloid volume and the recreation of whole blood fro
287                                        Total crystalloid volume during the first 48 hrs post burn, to
288                                              Crystalloid volume was associated with increased mortali
289 e monitoring, colloids, steroids, and larger crystalloid volumes (median 7 vs 5 L).
290 ally similar except that men required higher crystalloid volumes, more often had a history of alcohol
291            After 1 hr shock, shed blood plus crystalloid was administered for resuscitation.
292                                              Crystalloid was initiated significantly later with comor
293  cold (4 degrees C) antegrade BCP (8:1 blood:crystalloid) was delivered every 20 minutes for the firs
294      After 1 hr, shed blood and supplemental crystalloid were administered for resuscitation.
295 ated above-average doses of vasopressors and crystalloids were associated with improved outcomes when
296 nstead, aberrant spherical virions and large crystalloids were seen.
297 l adults have associated receipt of balanced crystalloids with lower rates of complications, includin
298                    Trials comparing balanced crystalloids with normal saline have yielded mixed resul
299  (hazard ratio, 0.53-0.75; p < 0.001), 1-2 L crystalloids within the first 6 hours (hazard ratio 0.67

 
Page Top